The development of antivirals and its main challenges

Overcoming political challenges to the transformation of mental health systems and servicesПодробнее

New antibiotics, challenges and possibilities: A Conversation with Manica BalasegaramПодробнее

Challenges Using High Throughput Sequencing for the Regulatory Review of Antiviral DrugsПодробнее

Navigating Early Clinical Drug Development Challenges by Dr. Sara Glickstein of GenentechПодробнее

Dr. Anthony Fauci on COVID-19: Lessons Learned and Remaining Challenges | Rhoads Medal Lecture 2022Подробнее

Debate: In patients with both CMV and steroid refractory UC, you must treat the CMV, but not the UCПодробнее

"It's an Adventure. Every Project Takes You To A New Place."Подробнее

Challenges Facing HIV/AIDS Vaccine DevelopmentПодробнее

Clinical development of antimicrobials – Phase 1 development challengesПодробнее

James Bradner: "Small molecule therapeutics" (11/24/2020)Подробнее

Viral Threats to Humankind: Antivirals and Lessons Learned from InterferonsПодробнее

COVID-19 PATIENT MANAGEMENT: Insights, Treatments and ChallengesПодробнее

Overcome challenges in vaccine development with deeper antigen stability characterizationПодробнее

Ninja Nerds, ASSEMBLE!Подробнее

Human viral challenge studies / Dr Anthony Gilbert - Retroscreen Virology - World Vaccine CongressПодробнее

TWiV 863: Does this challenge study pass the smell test?Подробнее

Coronavirus Special Report: Medicine's Critical ChallengeПодробнее

Crossroads: Challenges and Opportunities in Malaria Vaccine DevelopmentПодробнее

Directly acting antiviral agents vs Host directed antiviral agents | DAAs vs HDAs|Подробнее

The challenges of developing a COVID-19 vaccineПодробнее

08. Could a Surface Science approach revolutionize antiviral drug development?Подробнее